Experience

• 

  Indian Pharmacopoeia Commission

  • India
  • Pharmaceutical Manufacturing
  • 300 - 400 Employee

  • Sr. Pharmacovigilance Associate (Research Scientist)

    • Nov 2016 - Present

    (1) Team Lead- National Health Programme Integration with NCC-PvPI (Current), PV Regulatory Affairs Division (Earlier).(2) Coordination with various National Health Programmes.(3) Use of VigiGrade and VigiFlow for the Individual Case Safety Reports (ICSRs) reporting and quality.(4) Uses MedDRA for the coding of various medical terms and Adverse Drug Reactions (ADR).(5) Analyzes the Adverse Drug Reaction (ADR) data received from various ADR monitoring Centres (AMCs) using VigiLyze.(6) Strong coordination and effective communication with the respective programme officers and World Health Organization (WHO), Country office India.(7) Maintains the track on the Initial as well as follow-up reports received from the various ADR Monitoring Centres, Health Care Professionals etc for the quality of the data regarding ICSRs.(8) Working as an active team player for quality and quantity of the ICSRs from various ADR monitoring Centres (AMCs) throughout the country.(9) Engaged in Periodic Safety Update Reports (PSUR) review and also involved with the Signal Detection Division for the signal detection related activities with the vaccines and other medical products.(10) Involved in providing field level, state level as well as National level trainings for the upcoming professionals in the field of patient safety and healthcare.(11) Involved in national and international cooperation such as the National Regulatory Authority i.e. Central Drugs Standard Control Organization (CDSCO) and WHO country office & SEARO office.(12) Preparing the scientific reports, drafting & compiling various reports, preparation of action plans etc.(13) Looking after all the activities associated with the Vigilance of vaccine safety. Coordination with the AEFI-ITSU Secretariat for various National AEFI committee meetings and also provide monthly updates to the MoHFW reg the vaccine safety.

  • Pharmacovigilance Associate

    • Sep 2016 - Nov 2016

    (1) Working as an active team player for quality and quantity of the ICSRs from various ADR monitoring Centres (AMCs).(2) Reporting of various reports from the industry to the WHO database.(3) Use of Vigigrade and Vigiflow for the ICSRs reporting and quality.(4) Uses WHO-ART for the reporting.(5) Maintains the track on the Initial as well as follow-up reports received from the various ADR Monitoring Centres, Health Care Professionals, Regulatory Authority (CDSCO) etc for the quality of the data regarding ICSRs.(6) Looking after the voluntary reporting from various HCPs throughout the country.

• 

  Wipro HLS (A Division of Wipro Ltd.)

  • Sarita Vihar, New Delhi

  • Pharmacovigilance Officer

    • Oct 2015 - Aug 2016
    • Sarita Vihar, New Delhi

    Perform book-in function in ARGUS safety database for Initial reports.• Ensure, a duplicate check has been conducted against the ARGUS Safety Database in accordance with SOPs in order to avoid case duplication.•Whole Case Processing: Product coding, Event assessment, Seriousness criteria, Narrative writing and conducting all the required follow-up activities as required in the ARGUS safety database.•Coding of Adverse events, Product indications, Lab data, and Medical histories etc. using Med DRA dictionary. Coding of Products i.e. both Suspect and Concomitant medications using CDD and WHO drug dictionary.•Perform follow-ups and company notifications, LPs with the company.

• 

  MM (Deemed to be University) Official

  • Mullana, Ambala

  • Assistant Professor

    • Aug 2014 - Sep 2015
    • Mullana, Ambala

    (1) Teaching to Pharm.D. 2nd, 3rd, 4th & 5th Year students. There were about 100 students under my guidance, during the academic year. (2) Provided training about Clinical Research, Pharmacovigilance (PvPI), Clinical Skills, Patient Care / safety, Pharmacotherapeutics, Community Pharmacy etc. (3) Organized Continuing Pharmacy Education Program under HSPC and various conferences at MM University. (4) Provided Patient counseling, Drug Information Services at MM Hospital. (5) Worked a member of Personality development committee from MMCP, MMU. (6) Played an important role during the inspection from the Pharmacy Council of India. (7) Planned and organized the work before the due date for the internal as well as external audits. (8) Worked as a Mentor for about 20 students, and provided them with solutions regarding the problems with their studies during the academic year 2014-15.

• 

  JSS University (Jagadguru Sri Shivarathreeshwara University),Mysore

  • Mysore, Karnataka

  • Clinical Pharmacist/Pharm. D. Intern

    • Jul 2013 - Jun 2014
    • Mysore, Karnataka

    • Initial data entry of case reports into VigiFlow (version 5.3) part of International Drug Monitoring Programme WHO received from companies and Helpline Number• Case processing of Serious Adverse Events (SAEs) & non serious event• Coding Reaction and Drugs using WHO-ART & WHO-DD• Responsible for assessing case reports for seriousness and causality• Writing case narratives.• Identification of SUSARs (Suspected Unexpected Serious Adverse reactions)• To prepare write ups for newsletters, Guidance Document, pamphlets at NCC-PvPI• Patient Counselling, Minimize drug related problems, Drug Information, Patient referrals.• Adverse Event Followin Immunization (AEFI), PvPI, GoI, Reporting and follow up.

• 

  Primary Healthcare Centre

  • Agra, Uttar Pradesh, India

  • Pharmacist

    • Jul 2010 - Jun 2011
    • Agra, Uttar Pradesh, India

• 

  Ranbaxy

  • Ponta Sahib, Himanchal Pradesh

  • Trainee Pharmacist

    • Jul 2006 - Jul 2006
    • Ponta Sahib, Himanchal Pradesh

    Manufacturing chemist trainee